These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10078602)

  • 1. Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum.
    Argiro L; Henri S; Dessein H; Dessein AJ; Bourgois A
    Vaccine; 1999 Jan; 17(1):13-8. PubMed ID: 10078602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of a protection against S. mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorption with GM-CSF on alum.
    Argiro L; Henri S; Dessein H; Kouriba B; Dessein AJ; Bourgois A
    Vaccine; 2000 Apr; 18(19):2033-8. PubMed ID: 10706966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH.
    Argiro LL; Kohlstädt SS; Henri SS; Dessein HH; Matabiau VV; Paris PP; Bourgois AA; Dessein AJ
    Vaccine; 2000 Apr; 18(19):2039-48. PubMed ID: 10706967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against
    Alves CC; Araujo N; Bernardes WPOS; Mendes MM; Oliveira SC; Fonseca CT
    Front Immunol; 2018; 9():2488. PubMed ID: 30450095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
    Tallima H; Tadros MM; El Ridi R
    Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase.
    Tallima H; Dvořák J; Kareem S; Abou El Dahab M; Abdel Aziz N; Dalton JP; El Ridi R
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005443. PubMed ID: 28346516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aluminum hydroxide associated to Schistosoma mansoni 22.6 kDa protein abrogates partial protection against experimental infection but not alter interleukin-10 production.
    Pacífico LG; Fonseca CT; Barsante MM; Cardoso LS; Araújo MI; Oliveira SC
    Mem Inst Oswaldo Cruz; 2006 Sep; 101 Suppl 1():365-8. PubMed ID: 17308799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human and murine humoral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase is associated with resistance to Schistosomiasis.
    El Ridi R; Mahrous A; Afifi A; Montash M; Velek J; Jezek J
    Scand J Immunol; 2001 Nov; 54(5):477-85. PubMed ID: 11696199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of mice with a 30 kDa Schistosoma antigen with and without human adjuvant induces high protection against S. mansoni infection.
    Attallah AM; Abdel Aziz MM; Abbas AT; Elbakry KA; El-Sharabasy MM
    J Helminthol; 2004 Sep; 78(3):189-94. PubMed ID: 15469619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant.
    Mountford AP; Anderson S; Wilson RA
    J Immunol; 1996 Jun; 156(12):4739-45. PubMed ID: 8648120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Schistosoma mansoni cyclophilin A epitope 107-121 induces a protective immune response against schistosomiasis.
    de Melo TT; Mendes MM; Alves CC; Carvalho GB; Fernandes VC; Pimenta DLF; de Moraes Mourão M; Gai F; Kalli M; Coelho A; de Azambuja Ribeiro RIM; Falcone FH; Pereira RADS; Fonseca CT
    Mol Immunol; 2019 Jul; 111():172-181. PubMed ID: 31063938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunization of mice against Schistosoma mansoni with purified adult worm surface membranes.
    Smithers SR; Hackett F; Ali PO; Simpson AJ
    Parasite Immunol; 1989 Jul; 11(4):301-18. PubMed ID: 2476710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schistosoma mansoni phosphofructokinase: immunolocalization in the tegument and immunogenicity.
    Mansour JM; McCrossan MV; Bickle QD; Mansour TE
    Parasitology; 2000 May; 120 ( Pt 5)():501-11. PubMed ID: 10840980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-12 as an adjuvant for an antischistosome vaccine consisting of adult worm antigens: protection of rats from cercarial challenge.
    Bungiro RD; Goldberg M; Suri PK; Knopf PM
    Infect Immun; 1999 May; 67(5):2340-8. PubMed ID: 10225893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the protective immune response induced in mice by immunization with Schistosoma mansoni schistosomula tegument (Smteg) in association with CpG-ODN.
    Teixeira de Melo T; Araujo JM; Campos de Sena I; Carvalho Alves C; Araujo N; Toscano Fonseca C
    Microbes Infect; 2013 Jan; 15(1):28-36. PubMed ID: 23099420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of adjuvant on induction of protective immunity by a non-living vaccine against schistosomiasis.
    James SL; Pearce EJ
    J Immunol; 1988 Apr; 140(8):2753-9. PubMed ID: 3128608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4.
    Siddiqui AA; Phillips T; Charest H; Podesta RB; Quinlin ML; Pinkston JR; Lloyd JD; Paz M; Villalovos RM; Pompa J
    Infect Immun; 2003 Jul; 71(7):3844-51. PubMed ID: 12819068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines.
    Disis ML; Bernhard H; Shiota FM; Hand SL; Gralow JR; Huseby ES; Gillis S; Cheever MA
    Blood; 1996 Jul; 88(1):202-10. PubMed ID: 8704175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
    Ricciardi A; Dalton JP; Ndao M
    Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zhang W; Ahmad G; Molehin AJ; Torben W; Le L; Kim E; Lazarus S; Siddiqui AJ; Carter D; Siddiqui AA
    J Investig Med; 2018 Dec; 66(8):1124-1132. PubMed ID: 29997146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.